Evidence map›Paper›PMID 22151823›Full record

ArticleBMC bioinformatics2011

A linear classifier based on entity recognition tools and a statistical approach to method extraction in the protein-protein interaction literature.

Anália Lourenço, Michael Conover, Andrew Wong, Azadeh Nematzadeh, Fengxia Pan, Hagit Shatkay, Luis M Rocha

Erratum issuedAbstract read
In one paragraph

Article in BMC bioinformatics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Hagit Shatkay-Reshef 1965-2022.Bioinformatics advances · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors.

Anália LourençoInstitute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, Braga, Portugal.
Michael Conover
Andrew Wong
Azadeh Nematzadeh
Fengxia Pan
Hagit Shatkay
Luis M Rocha

Funding

Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and ClinicalR01LM011945 · NLM · INDIANA UNIVERSITY INDIANAPOLIS · PI LI, LANG, ROCHA, LUIS M · 2014 to 2017
$1.8M
6 · The paper itself

Abstract

backgroundWe participated, as Team 81, in the Article Classification and the Interaction Method subtasks (ACT and IMT, respectively) of the Protein-Protein Interaction task of the BioCreative III Challenge. For the ACT, we pursued an extensive testing of available Named Entity Recognition and dictionary tools, and used the most promising ones to extend our Variable Trigonometric Threshold linear classifier. Our main goal was to exploit the power of available named entity recognition and dictionary tools to aid in the classification of documents relevant to Protein-Protein Interaction (PPI). For the IMT, we focused on obtaining evidence in support of the interaction methods used, rather than on tagging the document with the method identifiers. We experimented with a primarily statistical approach, as opposed to employing a deeper natural language processing strategy. In a nutshell, we exploited classifiers, simple pattern matching for potential PPI methods within sentences, and ranking of candidate matches using statistical considerations. Finally, we also studied the benefits of integrating the method extraction approach that we have used for the IMT into the ACT pipeline.

resultsFor the ACT, our linear article classifier leads to a ranking and classification performance significantly higher than all the reported submissions to the challenge in terms of Area Under the Interpolated Precision and Recall Curve, Mathew's Correlation Coefficient, and F-Score. We observe that the most useful Named Entity Recognition and Dictionary tools for classification of articles relevant to protein-protein interaction are: ABNER, NLPROT, OSCAR 3 and the PSI-MI ontology. For the IMT, our results are comparable to those of other systems, which took very different approaches. While the performance is not very high, we focus on providing evidence for potential interaction detection methods. A significant majority of the evidence sentences, as evaluated by independent annotators, are relevant to PPI detection methods.

conclusionsFor the ACT, we show that the use of named entity recognition tools leads to a substantial improvement in the ranking and classification of articles relevant to protein-protein interaction. Thus, we show that our substantially expanded linear classifier is a very competitive classifier in this domain. Moreover, this classifier produces interpretable surfaces that can be understood as "rules" for human understanding of the classification. We also provide evidence supporting certain named entity recognition tools as beneficial for protein-interaction article classification, or demonstrating that some of the tools are not beneficial for the task. In terms of the IMT task, in contrast to other participants, our approach focused on identifying sentences that are likely to bear evidence for the application of a PPI detection method, rather than on classifying a document as relevant to a method. As BioCreative III did not perform an evaluation of the evidence provided by the system, we have conducted a separate assessment, where multiple independent annotators manually evaluated the evidence produced by one of our runs. Preliminary results from this experiment are reported here and suggest that the majority of the evaluators agree that our tool is indeed effective in detecting relevant evidence for PPI detection methods. Regarding the integration of both tasks, we note that the time required for running each pipeline is realistic within a curation effort, and that we can, without compromising the quality of the output, reduce the time necessary to extract entities from text for the ACT pipeline by pre-selecting candidate relevant text using the IMT pipeline.

Indexed as

Data MiningHumansNatural Language ProcessingPeriodicals as TopicProteinsProteins

Identifiers

PMID22151823
PMCPMC3269935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.